Elypta Company

Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring

Technology: Small Molecules
Headquarters: Stockholm, Stockholms Lan, Sweden
Funding Status: Seed
Founded Date: 2017
Estimated Revenue: Less than $1M
Employee Number: 11-50
Industry: PharmTech
Investor Type: For Profit